PDCD1 and head and neck squamous cell carcinoma: We validated by scRNAseq, flow cytometry, and multispectral microscopy that macrophages are the key contributors of PD-L1 in the HNSCC TME, paralleling clinical significance and the widespread use of the combined positive score (CPS) as a biomarker for PD-1-based immunotherapy57.